Lurasidone side effects: akathisia, food requirements, sedation

Lurasidone, marketed as Latuda, occupies a useful niche among atypical antipsychotics. It is reliably effective for schizophrenia and bipolar depression, has a relatively gentle metabolic profile, and is dosed once daily. The catches are concrete: it must be taken with a meal of at least 350 calories, akathisia is one of its most common side effects, and the dosing range matters more than with many other agents. Knowing these specifics ahead of time is the difference between a productive trial and a frustrating one.

The meal requirement

Lurasidone's absorption is roughly tripled when taken with a meal of at least 350 calories. The original phase III trials all required food, and the FDA labelling — available through Drugs@FDA — is explicit. Without food, blood levels are inconsistent and symptom control suffers.

The 350-calorie threshold is forgiving compared with ziprasidone's 500 — a typical dinner, a substantial sandwich, or a hearty breakfast usually clears it — but it cannot be skipped. Patients whose appetite is suppressed by negative symptoms or other medications may need help building a reliable evening routine.

Akathisia

Akathisia is the most common reason patients struggle with lurasidone. It is dose-dependent: at 40–80 mg the rate is in single digits in most trials; at 120–160 mg it can reach 15% or higher. Patients describe an inner restlessness, an inability to sit still, and sometimes pacing or rocking.

Strategies, in rough order of preference:

• Lower the dose if clinically possible
• Add a beta-blocker (often propranolol)
• Short-term benzodiazepine support
• Switch to a different antipsychotic if akathisia persists

For more, see our akathisia guide.

Sedation and somnolence

Sedation is moderate and usually less than olanzapine or quetiapine but more than aripiprazole. Most prescribers dose lurasidone with the evening meal to take advantage of the sleep effect; some patients do better with a midday dose if morning grogginess is a problem.

Weight and metabolic effects

This is where lurasidone earns its place. Average weight gain in the first year is small — typically in the 1–2 kg range, similar to aripiprazole and ziprasidone, and well below olanzapine. Effects on fasting glucose and lipids are modest. The Leucht 2013 network meta-analysis placed lurasidone among the most metabolically friendly antipsychotics, a finding broadly confirmed in real-world studies.

That said, "average" is not "everyone." Standard metabolic monitoring still applies: weight, BMI, fasting glucose and lipids at baseline, three months, and yearly thereafter.

Nausea and gastrointestinal effects

Nausea is fairly common in the first weeks, particularly during titration. Taking lurasidone at the end of a meal rather than at the very start often helps. Most patients adjust within a few weeks.

Movement effects beyond akathisia

Lurasidone can cause parkinsonism (tremor, stiffness, slowed movement) and dystonia, both more common at higher doses. Long-term use carries some risk of tardive dyskinesia, though the risk appears lower than with first-generation antipsychotics. Regular AIMS screening is reasonable.

Prolactin

Lurasidone causes only mild prolactin elevation in most patients, less than risperidone or paliperidone. Symptomatic hyperprolactinemia is uncommon at standard doses, though not impossible.

Other effects

• Insomnia or activation — particularly if dosed in the morning rather than evening
• Dizziness and orthostatic hypotension — modest
• Dry mouth — generally mild
• QT effects — minimal at standard doses; lurasidone has one of the smaller QT signals among antipsychotics

Drug interactions to know

Lurasidone is metabolised primarily by CYP3A4. Strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir, grapefruit juice) substantially raise blood levels and are contraindicated. Strong CYP3A4 inducers (rifampin, phenytoin, St. John's wort) lower levels enough to make the medication ineffective and are also contraindicated. Always tell your prescriber about other medications and supplements.

Rare but serious

When to call the prescriber

• Restlessness becoming unbearable
• Inability to take with food consistently
• New tremor, stiffness, or unusual movements
• Significant weight changes
• Starting any new medication, including over-the-counter or supplements

Switching considerations

If lurasidone is not the right fit, similar metabolically friendly options include:

• Aripiprazole — no food requirement, partial agonist mechanism
• Ziprasidone — also food-dependent (500 calories), QT considerations (see ziprasidone side effects)
• Cariprazine — long half-life, partial agonist, no food requirement
• Lumateperone — newer, simple dosing, less long-term data

Why patients pick lurasidone

The most common reason is a prior bad experience with weight gain on olanzapine or quetiapine, paired with a need for an effective option for bipolar depression — an indication where lurasidone has particularly strong evidence. Patients who can build the meal routine and weather the early akathisia often do well on it for years.

This article is for educational purposes only and is not medical advice. Information is summarised from publicly available FDA labelling and peer-reviewed literature. Always consult your prescribing clinician before starting, stopping, or changing any medication. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.